Hmmmm... Another 1Q beat who could ever have seen this coming... I thought we were going second leg down? Gee I wonder where J&J gets the munnie for their pharma?
Johnson & Johnson reported earnings that beat analysts’ estimates on strong sales of pharmaceuticals, the company’s biggest division. Drugs including Stelara, a psoriasis drug, and Xarelto, a blood thinner, were among the company’s major drug products that surpassed analysts’ expectations.
Pharmaceutical sales have surpassed medical devices and consumer health products to become New Brunswick, New Jersey-based J&J’s biggest division.
Drug sales help Johnson & Johnson earnings to beat estimates https://t.co/bTlOotdMmU pic.twitter.com/4buioKgKkC— Bloomberg (@business) April 19, 2016